Blood Markers For Diagnosing Epithelium Derived Cancers And Monoclonal Antibodies Thereof
|Document №||Publication date||Filed Date||Application №|
|9255142||February 9, 2016||September 9, 2010||13/821844|
The present invention provides uses of cytokeratins as markers for diagnosing epithelium derived cancers. The present invention provides cancer-related epitopes of cytokeratins and monoclonal antibodies which specifically recognize the epitopes. The present invention also provides methods for the early screen, diagnosis or prognosis of epithelium derived cancers in subjects, methods for the evaluation of therapeutic effect of related medicaments or therapies, and kits for accomplishing the methods.